14 Sep, 2020 RNAi Roundtable: Givosiran, for the Treatment of Acute Hepatic Porphyria
On September 14, 2020, we hosted an online RNAi Roundtable to review progress with givosiran, an RNAi therapeutic for the treatment of acute hepatic porphyria.
Akin Akinc, Ph.D.
Vice President & General Manager, Givosiran
Senior Director, U.S. Business Lead
Amy Simon, M.D.
Vice President, Clinical Research